Background: The BDI-II is still widely used to assess the importance of depressive symptoms in persons with MS (PwMS), despite recent recommendations to use a reduced and adapted form of this screening tool (BDI-FS).
Method: We compared the prevalence of depressive symptoms in 329 PwMS which completed both the BDI-II and the BDI-FS and test the agreement between both screening tools.
Results: The BDI-FS shows a lower overall prevalence of depression but not for severe cases.
Conclusion: It is crucial to raise awareness about the potential implications of choosing either of these tools in the context of MS.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.msard.2024.106220 | DOI Listing |
Publication Analysis
Top Keywords
depressive symptoms
8
comparative analysis
4
analysis depression
4
depression screening
4
screening tools
4
tools multiple
4
multiple sclerosis
4
sclerosis implications
4
implications diagnosis
4
diagnosis prevalence
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!